IOL CHEMICALS & PHARM. | ZOTA HEALTH CARE | IOL CHEMICALS & PHARM./ ZOTA HEALTH CARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | -126.9 | - | View Chart |
P/BV | x | 1.5 | 15.9 | 9.4% | View Chart |
Dividend Yield | % | 1.0 | 0.2 | 500.8% |
IOL CHEMICALS & PHARM. ZOTA HEALTH CARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ZOTA HEALTH CARE Mar-23 |
IOL CHEMICALS & PHARM./ ZOTA HEALTH CARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 378 | 142.1% | |
Low | Rs | 272 | 225 | 121.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 55.6 | 679.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | -2.3 | -1,032.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 2.5 | 1,284.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.00 | 400.0% | |
Avg Dividend yield | % | 1.0 | 0.3 | 298.0% | |
Book value per share (Unadj.) | Rs | 256.8 | 31.9 | 804.1% | |
Shares outstanding (eoy) | m | 58.71 | 25.16 | 233.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.4 | 19.8% | |
Avg P/E ratio | x | 17.1 | -131.3 | -13.0% | |
P/CF ratio (eoy) | x | 12.8 | 122.6 | 10.5% | |
Price / Book Value ratio | x | 1.6 | 9.4 | 16.7% | |
Dividend payout | % | 16.9 | -43.6 | -38.7% | |
Avg Mkt Cap | Rs m | 23,743 | 7,581 | 313.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 121 | 1,384.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,399 | 1,585.1% | |
Other income | Rs m | 256 | 26 | 976.0% | |
Total revenues | Rs m | 22,427 | 1,425 | 1,573.9% | |
Gross profit | Rs m | 2,257 | 72 | 3,131.7% | |
Depreciation | Rs m | 462 | 120 | 386.1% | |
Interest | Rs m | 165 | 26 | 642.4% | |
Profit before tax | Rs m | 1,887 | -47 | -4,021.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 11 | 4,575.8% | |
Profit after tax | Rs m | 1,391 | -58 | -2,410.2% | |
Gross profit margin | % | 10.2 | 5.2 | 197.6% | |
Effective tax rate | % | 26.2 | -23.1 | -113.8% | |
Net profit margin | % | 6.3 | -4.1 | -152.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 842 | 1,148.5% | |
Current liabilities | Rs m | 5,025 | 405 | 1,240.3% | |
Net working cap to sales | % | 20.9 | 31.2 | 67.1% | |
Current ratio | x | 1.9 | 2.1 | 92.6% | |
Inventory Days | Days | 43 | 20 | 216.9% | |
Debtors Days | Days | 8 | 726 | 1.1% | |
Net fixed assets | Rs m | 11,017 | 728 | 1,512.9% | |
Share capital | Rs m | 587 | 252 | 233.3% | |
"Free" reserves | Rs m | 14,490 | 552 | 2,625.2% | |
Net worth | Rs m | 15,077 | 804 | 1,876.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,570 | 1,317.5% | |
Interest coverage | x | 12.5 | -0.8 | -1,500.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.9 | 120.3% | |
Return on assets | % | 7.5 | -2.0 | -368.0% | |
Return on equity | % | 9.2 | -7.2 | -128.5% | |
Return on capital | % | 13.6 | -2.6 | -513.8% | |
Exports to sales | % | 26.7 | 14.0 | 190.7% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 196 | 3,022.3% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 196 | 3,022.3% | |
Fx outflow | Rs m | 6,052 | 3 | 179,578.6% | |
Net fx | Rs m | -122 | 193 | -63.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -20 | -6,095.2% | |
From Investments | Rs m | -1,200 | 147 | -816.1% | |
From Financial Activity | Rs m | -41 | -139 | 29.6% | |
Net Cashflow | Rs m | -18 | -12 | 155.4% |
Indian Promoters | % | 48.2 | 66.2 | 72.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 33.9 | 153.1% | |
Shareholders | 130,003 | 7,589 | 1,713.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.3 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ZOTA HEALTH CARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -0.98% | -0.44% |
1-Month | -4.51% | 3.05% | 2.15% |
1-Year | -4.09% | 67.74% | 49.82% |
3-Year CAGR | -12.01% | 46.24% | 14.21% |
5-Year CAGR | 15.35% | 19.64% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ZOTA HEALTH CARE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ZOTA HEALTH CARE the stake stands at 66.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ZOTA HEALTH CARE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ZOTA HEALTH CARE paid Rs 1.0, and its dividend payout ratio stood at -43.6%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ZOTA HEALTH CARE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.